followed by 50mg every 12h and optional adjunctive therapy with ceftazidime 2g iv every 8h for Pseudomonas aeruginosa coverage with imipenem 500mg to 1g iv every 8h (optional adjunctive therapy ...

1. Mena KD, Gerba CP. Risk Assessment of Pseudomonas aeruginosa in Water. Reviews of Environmental Contamination and Toxicology, Vol 201 2009;201:71-115. doi:10.1007 ...

The research team led by Pierre Stallforth, professor at the University of Jena and head of department at the Leibniz-HKI, has now identified a previously unknown defense mechanism of Pseudomonas ...

Center of Pharmaceutical Engineering (PVZ), Technische Universität Braunschweig, Franz-Liszt-Straße 35a, 38106 Braunschweig, Germany Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) - ...

2014). A PK/PD target of 40% f T > MIC was obtained for imipenem. Despite the high incidence of ARC among burn patients, an imipenem dose of 500 mg q6h was adequate for simulated burns treated via ...